These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8969320)

  • 1. The proper role for discounting. Search in progress.
    Lipscomb J
    Med Care; 1996 Dec; 34(12 Suppl):DS119-23. PubMed ID: 8969320
    [No Abstract]   [Full Text] [Related]  

  • 2. Update and evaluation of Australian guidelines. Government perspective.
    Mitchell A
    Med Care; 1996 Dec; 34(12 Suppl):DS216-25. PubMed ID: 8969329
    [No Abstract]   [Full Text] [Related]  

  • 3. The consequence of production loss or increased costs of production.
    Koopmanschap MA; Rutten FF
    Med Care; 1996 Dec; 34(12 Suppl):DS59-68. PubMed ID: 8969315
    [No Abstract]   [Full Text] [Related]  

  • 4. Accumulating evidence for the case of differential discounting.
    Postma MJ; Parouty M; Westra TA
    Expert Rev Clin Pharmacol; 2013 Jan; 6(1):1-3. PubMed ID: 23272787
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug therapy: safety, effectiveness, and economics.
    Brandys J
    Przegl Lek; 2001; 58(4):226-8. PubMed ID: 11450340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of quality of care--can we afford it?
    Payne BC
    Forum Med; 1979 Apr; 2(4):297-9. PubMed ID: 10308855
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness: tool or trap?
    Prescott PA
    Nurs Outlook; 1979 Nov; 27(11):722-8. PubMed ID: 116198
    [No Abstract]   [Full Text] [Related]  

  • 8. Standardization of the economic evaluation of health technologies. European developments.
    Rovira J
    Med Care; 1996 Dec; 34(12 Suppl):DS182-8. PubMed ID: 8969325
    [No Abstract]   [Full Text] [Related]  

  • 9. Incorporating model uncertainty in cost-effectiveness analysis: a Bayesian model averaging approach.
    Negrín MA; Vázquez-Polo FJ
    J Health Econ; 2008 Sep; 27(5):1250-9. PubMed ID: 18490067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug and health outcomes measurement in clinical practice.
    Ibern P
    Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():45-6. PubMed ID: 9800730
    [No Abstract]   [Full Text] [Related]  

  • 11. Measuring the "payoff" of worksite health strategies.
    Stason WB
    Bus Health; 1984 Mar; 1(4):19-22. PubMed ID: 10310429
    [No Abstract]   [Full Text] [Related]  

  • 12. Difficult decisions: weighing treatment costs and benefits.
    Wainio JA
    Hosp Technol Ser; 1995 Jan; 14(1):1-3. PubMed ID: 10140805
    [No Abstract]   [Full Text] [Related]  

  • 13. High risk, low assessment. A talk with Ellen Silbergeld. Interview by Carl Blumenthal.
    Silbergeld E
    Health PAC Bull; 1984; 15(5):19-22. PubMed ID: 10310903
    [No Abstract]   [Full Text] [Related]  

  • 14. Using care process models to improve quality while controlling cost.
    Pehrson G
    Qual Lett Healthc Lead; 1994 Apr; 6(3):24-7. PubMed ID: 10133647
    [No Abstract]   [Full Text] [Related]  

  • 15. Current efforts in standards development. United States.
    Power EJ
    Med Care; 1996 Dec; 34(12 Suppl):DS200-3; discussion DS204-7. PubMed ID: 8969327
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuria.
    Postma MJ; Boersma C; Gansevoort RT
    Nephrol Dial Transplant; 2008 Apr; 23(4):1103-6. PubMed ID: 17210586
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacoeconomics.
    Sule NS; Nerurkar RP; Kamath SA
    J Assoc Physicians India; 2002 Aug; 50():1057-62. PubMed ID: 12421032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cost effectiveness analysis in health care evaluation.
    Atherly A; Culler SD; Becker ER
    Q J Nucl Med; 2000 Jun; 44(2):112-20. PubMed ID: 10967622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current principles and application of pharmacoeconomics.
    Malek M
    Pharmacoeconomics; 1996; 9 Suppl 1():1-8. PubMed ID: 10160111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach for assessment of IT programs in health care.
    Farcaş DD; Cristea C; Ripanu A; Oprişan M
    Stud Health Technol Inform; 1997; 43 Pt B():844-8. PubMed ID: 10179787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.